Kedudukan dalam Saham
#39874
OKYO Pharma Limited, a biopharmaceutical entity operating at the preclinical... OKYO Pharma Limited, a biopharmaceutical entity operating at the preclinical stage, focuses on creating treatments for individuals experiencing inflammatory conditions of the eye and chronic ocular pain. Established in 2007 and headquartered in London, UK, the company's primary investigational drug is OK-101, aimed at addressing dry eye syndrome. Additionally, the firm is advancing OK-201, a preclinical analogue developed from bovine adrenal medulla, designed to alleviate neuropathic ocular pain.
Harga Saham
$0.01904982
Disegerakkan terakhir: 2023-05-19
Perubahan (1 hari)
-17.05%
Perubahan (1 tahun)
0.00%
Perdagangan OKYO Pharma Limited (OKYO)
Harga OKYO dengan permodalan pasaran b
Modal pasaran bagi OKYO Pharma Limited(OKYO)
Modal Pasaran: $316.00K
Sehingga August 2026, OKYO Pharma Limited mempunyai modal pasaran sebanyak $316.00K. Ini menjadikan OKYO Pharma Limited syarikat ke-39874th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran OKYO Pharma Limited dari 2018 hingga 2026
OKYO berbanding dengan 5 teratas yang paling popular stocks
| Harga OKYO |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.470T
|
+1,730,885,236.75%
|
|
|
|
|
$4.467T
|
+1,413,645,505.50%
|
|
|
|
|
$4.174T
|
+1,321,022,707.56%
|
|
|
|
|
$3.700T
|
+1,170,923,261.32%
|
|
|
|
|
$2.854T
|
+903,282,796.14%
|
